Polycythemia Vera Market: Is 2026 the Year We Finally "Ditch...

adicionou um novo artigo Health

2026-02-13 06:55:13 - Traduzir

Polycythemia Vera Market: Is 2026 the Year We Finally "Ditch the Needle"?

In early 2026, the Polycythemia Vera Market is valued at $1.35 billion, standing at the threshold of a historical shift from "bloodletting" to "biological control." This year, the industry is electrified by the January 2026 FDA submission of rusfertide, a first-in-class hepcidin mimetic that could potentially eliminate the need for therapeutic phlebotomy for thousands of patients. This...

0 Comentários 0 Compartilhamentos 143 Visualizações 0 Anterior